REGENAPEP

REGENAPEP

FOR MUSCULOSKELETAL, RHEUMATIC AND ARTHRITIC PAIN RELIEF AND PREVENTIVE CARE

REGENAPEP is a new TGA-certified joint health supplement that acts as an advanced reliever of musculoskeletal, rheumatic and arthritic pain, and a preventive system against potential future onset of arthritis by alleviating conditions associated with early-stage musculoskeletal and joint inflammation.

This formula contains a unique active ingredient, colostrum (enriched with interleukin-1 receptor antagonist peptides), and a number of purified botanical extracts (turmeric, white willow, devil’s claw, boswellia serrate and ginger). All of the bioactive components in REGENAPEP’s formula interact synergistically to promote anti-inflammatory effects and pain relief.

INCREASE

Musculoskeletal and joint pain, pro-inflammatory cytokines and systemic inflammation

REDUCE

Cartilage degradation and regression or arthritic conditions

IMPROVE

Mobility and flexibility, cartilage regeneration and musculoskeletal protection

WHY US REGENAPEP DIFFERENT?

The natural ingredients in TGA-certified REGENAPEP activate a multidimensional cascade of anti-inflammatory processes, primarily through the inhibition of interleukin-1 and other proinflammatory cytokines, to relief pain and offer lasting musculoskeletal protection.

  • Multi-dimensional Anti-Inflammatory Action
  • Joint Protection and Regeneration
  • Natural Active Ingredients
  • Regulatory Certification

INGREDIENTS

1 tablet contains:

330mg Salix alba stem bark extract
Extraction ratio 25:1 equivalent to 8250mg

230mg Boswellia serata gum oleoresin extract
Extraction ratio 6:1 equivalent to 1380mg

100mg Zingiber officinale rhizome extract
Extraction ratio 10:1 equivalent to 1000mg

50mg Curcuma longa rhizhome extract
Extraction ratio 20:1 eqv to 1000mg

50mg Harpagophytum procumbens root extract
Extraction ratio 6:1 equivalent to 300mg

50mg Colostrum Glycomacropeptides

10mg Manganese Sulphate Monohydrate

Contraindications:

Not recommended to individuals who are under prescribed medications, pregnant and nursing, under 18 years of age, and lactose intolerant.

BLOCK PRO-INFLAMMATORY CYTOKINES AND SUPPRESS INFLAMMATION

REGENAPEP’s unique active ingredient, colostrum, is enriched with interleukin-1 receptor antagonist peptides (IL1RA) using a patent-pending production technology. IL1RA peptide, a natural amino acid complex, is a key blocker of the pro-inflammatory cytokine interleukin-1 (IL-1).

A significant body of research implicates IL-1 in the pathogenesis of arthritis. In both rheumatoid arthritis and osteoarthritis, IL-1 drives harmful musculoskeletal inflammation, leading to tissue destruction by inhibiting cell material synthesis and increasing the production of proteinase that are damaging to the overall joint structure. The effective inhibition of IL-1 using colostrum enriched with IL1RA peptides may significantly suppress inflammation and effectuate a cascade of ensuing benefits: pain reduction, prevention of disease deterioration and creation of better regenerative conditions for self-repair.

The botanical ingredients in REGENAPEP are demonstrated through clinical studies to cause anti-rheumatic and anti-inflammatory effects. They collectively block several inflammatory pathways by influencing cytokines that are key to causing inflammation.

Curcuma Longa reduces NF-κB, matrix metalloproteinases (MMPs) and prostaglandin E2; Salix Alba reduces IL-6 and TNF–α production; Harpagophytum Procumbens suppresses NF-κB and matrix metalloproteinases (MMPs); Boswellia Serrata decreases polymorphonuclear leukocyte infiltration and migration, and inhibits 5-lipoxygenase; Zingiber Officinale suppresses production of prostaglandin E2 and nitric oxide.

ACHIEVE SUSTAINABLE PAIN RELIEF

Inflammation is the primary cause of pain as tissue swelling adds pressure onto sensitive nerve endings at the inflamed area. The ingredients in REGENAPEP interact synergistically to relief pain by rapidly suppressing the underlying musculoskeletal and joint inflammation.

INCREASE CHONDROPROTECTION AND PREVENT WORSENING OF ARTHRITIC CONDITIONS

REGENAPEP’s IL1RA peptide (formulated as natural colostrum derivatives) and purified botanical ingredients not only relieve pain but also engender chondroprotective qualities. The ingredients may delay and reduce inflammatory degradation of articular cartilage, ultimately slowing down the deterioration of inflammatory-linked musculoskeletal and joint diseases, which may otherwise lead to expensive, highly invasive and risky surgical procedures (arthroplasty).

Harpagophytum Procumbens, a botanical ingredient in REGENAPEP, has a role in reducing cartilage degradation through the inhibition of matrix metalloproteinase (MMPs) and elastase.

PROMOTE BETTER REGENERATIVE CONDITIONS AND ATTAIN HEALTHY SKELETAL GROWTH

IL1RA peptides (enriched in REGENAPEP’s colostrum) suppress specific IL-1 pro-inflammatory cytokines to impede the progression of arthritic disease, provide secondary pain reduction effect and allow for better regenerative conditions to the cartilage and synovium.

Curcuma longa, a botanical ingredient in REGENAPEP, can potently induce heme oxygenase-1 (HO-1) expression, which ultimately promotes mesenchymal stem cell osteoblast differentiation and inhibits adipocyte differentiation.

Recent studies demonstrated that white willow extract could also stimulate new cartilage formation by exerting anabolic effects on articular chondrocyte in animal models.

ELEVATE MOOD AND REDUCE DEPRESSION ASSOCIATED WITH ARTHRITIS

Curcumin Longa, a botanical ingredient in REGENAPEP, is capable of causing natural and lasting anti-depressant effect by increasing brain derived neurotrophic factor (BDNF) in hippocampus, which may assist in targeting depression symptomatically associated with arthritis.

Recently, we conducted a large, in house, case study series, looking at the effect of REGENAPEP on arthritic patients.

89 patients, suffering from various arthritic conditions, were asked to take the REGENAPEP formulation, for 2 months, (The dosing was, 1 tablet 2 times a day).

At the end of the 60 days, an independent audit was conducted, where there 89 patients were contacted, and were asked a serious of questions to determine effectiveness of the treatment.

Areas treated with REGENAPEP, were

Elbows, Knees, Ankles, Shoulders, Wrists, Hips, Hands

Overall Audit Results:
Overall REGENAPEP Rating

  • 86% of patients believed REGENAPEP helped their condition
  • 78% of patients were satisfied with their improvement
  • 93% of patients would recommend Regenapep to others

Gender groups

  • Females = 83% believed REGENAPEP helped their condition
  • Males = 78% believed REGENAPEP helped their condition

Age groups

  • 18-40 = 78% believed REGENAPEP helped
  • 40-70 = 88% believed REGENAPEP helped
  • 70+ = 70% believed REGENAPEP helped

Average reduction in pain on a 10 point pain scale was 5.0 over all conditions

% of Patients that believed REGENAPEP helped their condition, gives us a break down of the specific areas that were targeted for treatment.

Patients taking Regenapep for joint issues.